Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Leucostim to Neupogen in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Leucostim (filgrastim)
• Neupogen (Filgrastim)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED